Cargando…
Exploiting vulnerabilities in cancer signalling networks to combat targeted therapy resistance
Drug resistance remains one of the greatest challenges facing precision oncology today. Despite the vast array of resistance mechanisms that cancer cells employ to subvert the effects of targeted therapy, a deep understanding of cancer signalling networks has led to the development of novel strategi...
Autores principales: | Harrison, Peter T., Huang, Paul H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Portland Press Ltd.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6204552/ https://www.ncbi.nlm.nih.gov/pubmed/30072489 http://dx.doi.org/10.1042/EBC20180016 |
Ejemplares similares
-
Exploiting vulnerabilities of cancer by targeting nuclear receptors of stromal cells in tumor microenvironment
por: Cheng, Hong Sheng, et al.
Publicado: (2019) -
Exploiting vulnerabilities of SWI/SNF chromatin remodelling complexes for cancer therapy
por: Wanior, Marek, et al.
Publicado: (2021) -
Targeting LKB1 in cancer – exposing and exploiting vulnerabilities
por: Momcilovic, M, et al.
Publicado: (2015) -
Exploiting metabolic vulnerabilities for personalized therapy in acute myeloid leukemia
por: Stuani, Lucille, et al.
Publicado: (2019) -
Ferroptosis and EMT: key targets for combating cancer progression and therapy resistance
por: Ren, Yuqing, et al.
Publicado: (2023)